Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors

Background: Long-term antiplatelet treatment is associated with major bleeding. Aims: To determine the costs associated with major bleeding in patients treated with aspirin-base...

Descripció completa

Dades bibliogràfiques
Autors principals:	Luengo-Fernandez, R, Li, L, Rothwell, PM
Format:	Journal article
Idioma:	English
Publicat:	SAGE Publications 2019

Ítems similars

Proton Pump Inhibitors Use in Patients With Ischemic Stroke on Dual Antiplatelet Therapy at Low Risk of Upper Gastrointestinal Bleeding
per: Minyoul Baik, et al.
Publicat: (2025-01-01)

Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study
per: Minyoul Baik, et al.
Publicat: (2024-06-01)

Antiplatelet agents and proton pump inhibitors &ndash; personalizing treatment
per: Eugene Lin, et al.
Publicat: (2010-06-01)

Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?
per: Oksana Mikhaylovna Drapkina, et al.
Publicat: (2011-10-01)

Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
per: Verónica Gamelas, et al.
Publicat: (2018-05-01)

The influence of changes in hospital drug formulary on the prescription of proton pump inhibitors
per: Raquel Vázquez-Mourelle, et al.
Publicat: (2017-01-01)

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
per: G Leontiadis, et al.
Publicat: (2007-12-01)

Antisecretory treatment efficacy by proton pump inhibitors at gastroduodenal ulcer bleedings
per: M. A. Evseyev, et al.
Publicat: (2010-06-01)

Are higher doses of proton pump inhibitors better in acute peptic bleeding?
per: Alejandro Villalón, et al.
Publicat: (2016-06-01)

BEHIND THE PROTON PUMP INHIBITOR PRESCRIPTION: AN INTERNATIONAL SURVEY ON PHYSICIAN PRACTICES AND KNOWLEDGE
per: Jean Félix PIÑERÚA-GONSÁLVEZ, et al.
Publicat: (2024-03-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
per: Mario Visconti
Publicat: (2015-09-01)

Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart
per: Giammarco Baiardi, et al.
Publicat: (2023-04-01)

Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome
per: Ashwin Radhakrishnan, et al.
Publicat: (2022-10-01)

The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications
per: O D Ostroumova, et al.
Publicat: (2019-08-01)

Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
per: Hilkens, NA, et al.
Publicat: (2020)

The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study
per: Yutaro Ide, et al.
Publicat: (2024-11-01)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
per: Yu-Hsi Hsieh, et al.
Publicat: (2013-01-01)

Appropriateness of proton pump inhibitors prescription in patients admitted to a Malaysian tertiary hospital
per: Then, Ru Fah, et al.
Publicat: (2019)

Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review
per: L. C. van Gestel, et al.
Publicat: (2024-06-01)

Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitors
per: O. D. Ostroumova, et al.
Publicat: (2019-11-01)

The consequences of long-term therapy with proton pump inhibitors
per: Zuzanna Drygała, et al.
Publicat: (2024-01-01)

Proton-pump inhibitors
per: Vasudevan G. Naidoo
Publicat: (2015-05-01)

Intermittent Proton Pump Inhibitor Therapy in Low-Risk Non-Variceal Upper Gastrointestinal Bleeding May Be Significantly Cost-Saving
per: Yang Lei, et al.
Publicat: (2023-07-01)

Significance of serological atrophic gastritis on proton pump inhibitor prescriptions and referrals to gastroscopy in the general population
per: Tor Persson, et al.
Publicat: (2024-09-01)

Non-prescription proton-pump inhibitors for self-treating frequent heartburn: the role of the Canadian pharmacist
per: Armstrong D, et al.
Publicat: (2016-12-01)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
per: Hyun-Jung Lee, et al.
Publicat: (2021-01-01)

Appropriateness of Antiplatelet Therapy and Proton Pump Inhibitor Prescribing in End-Stage Kidney Disease: A Retrospective Quality Investigation Study
per: Michael Che, et al.
Publicat: (2025-01-01)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
per: Simone Janett, et al.
Publicat: (2015-01-01)

Association of Long-term Use of Proton Pump Inhibitors with Mortality
per: Da Hyun Jung
Publicat: (2022-10-01)

Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation
per: Rajani Sharma, et al.
Publicat: (2017-05-01)

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan
per: Furitsu Shimada, et al.
Publicat: (2021-11-01)

Deprescribing proton pump inhibitors
per: Kim Jun Kevin Teh, et al.
Publicat: (2023-08-01)

Safety of proton pump inhibitors
per: Ye. A. Losik
Publicat: (2016-08-01)

Pharmacogenetics of proton pump inhibitors
per: M. V. Leonova
Publicat: (2015-12-01)

Cost-Effectiveness of Intravenous Proton Pump Inhibitors in High-Risk Bleeders
per: Sander Veldhuyzen van Zanten
Publicat: (2004-01-01)

The costly case of proton-pump inhibitors: a single-center experience
per: Vishnu Charan Suresh Kumar, et al.
Publicat: (2020-05-01)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
per: Cahir Caitriona, et al.
Publicat: (2012-11-01)

Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
per: Parata Chaiyana, et al.
Publicat: (2023-10-01)

Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use
per: Hsiu-Chi Cheng, et al.
Publicat: (2018-04-01)

Comorbid patient with GERD and cardiovascular disease receiving antiplatelet therapy. The possibilities of choosing a proton pump inhibitor on a case study
per: I. G. Pakhomova
Publicat: (2019-10-01)